BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1007566)

  • 1. [Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
    Delius W; Wirtzfeld A; Sebening H
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():197-200. PubMed ID: 1007566
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
    Pradella A; Codecà L; De Lorenzi E
    G Ital Cardiol; 1979; 9(7):763-6. PubMed ID: 540708
    [No Abstract]   [Full Text] [Related]  

  • 3. [General pharmacology of dobutamine].
    Pottecher T; Dupeyron JP; Gauthier-Lafaye PJ
    Ann Anesthesiol Fr; 1978; 19(10):845-51. PubMed ID: 35056
    [No Abstract]   [Full Text] [Related]  

  • 4. New catecholamines in clinical cardiovascular medicine.
    Leier CV
    Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
    G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
    Kupper W; Waller D; Hanrath P; Bleifeld W
    Eur Heart J; 1982 Feb; 3(1):29-34. PubMed ID: 7075609
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the hemodynamic effects induced with dobutamine, isoproterenol and dopamine in patients with coronary insufficiency].
    Magnani B; Ambrosioni E; Maresta A
    Boll Soc Ital Cardiol; 1977; 22(9):1570-4. PubMed ID: 753335
    [No Abstract]   [Full Text] [Related]  

  • 10. Dobutamine: a hemodynamic evaluation in human septic shock.
    Jardin F; Sportiche M; Bazin M; Bourokba A; Margairaz A
    Crit Care Med; 1981 Apr; 9(4):329-32. PubMed ID: 7214944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue AS
    Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dobutamine: a new synthetic cardioactive sympathetic amine.
    Sonnenblick EH; Frishman WH; LeJemtel TH
    N Engl J Med; 1979 Jan; 300(1):17-22. PubMed ID: 362214
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of dobutamine on hemodynamics, myocardial metabolism and mechanical efficiency in patients with old myocardial infarctions].
    Mihata S; Yasutomi N; Mori S; Komasa N; Nishian K; Tateishi J; Iwasaki T
    Kokyu To Junkan; 1987 May; 35(5):541-7. PubMed ID: 3616170
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of dobutamine in children with cardiovascular failure.
    Schranz D; Stopfkuchen H; Jüngst BK; Clemens R; Emmrich P
    Eur J Pediatr; 1982 Sep; 139(1):4-7. PubMed ID: 7173256
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle.
    DiSesa VJ; Brown E; Mudge GH; Collins JJ; Cohn LH
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):256-63. PubMed ID: 6977075
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of new inotropic drugs in clinical coronary heart failure.
    Jewitt D; Jennings K; Jackson PG
    Am J Med; 1978 Jul; 65(1):197-202. PubMed ID: 685994
    [No Abstract]   [Full Text] [Related]  

  • 17. [DPTI x CaO2/TTI changes and myocardial metabolism during dobutamine administration (author's transl)].
    Yamada T; Miyamoto H; Asano K
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Aug; 27(8):1125-31. PubMed ID: 501160
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
    Pozen RG; DiBianco R; Katz RJ; Bortz R; Myerburg RJ; Fletcher RD
    Circulation; 1981 Jun; 63(6):1279-85. PubMed ID: 7226474
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic effect of isoprenaline and dobutamine immediately after correction of tetralogy of Fallot. Relative importance of inotropic and chronotropic action in supporting cardiac output.
    Jaccard C; Berner M; Rouge JC; Oberhänsli I; Friedli B
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):862-9. PubMed ID: 6727409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
    Cyran J; Bolte HD
    Verh Dtsch Ges Inn Med; 1978; (84):683-6. PubMed ID: 742099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.